Results 171 to 180 of about 10,162 (193)

[Role of bone-density-conserving agents in the treatment for pain in patients with bone metastases].

Voprosy onkologii, 2015
Bones are the fourth area of metastases of malignant tumors that significantly burden the disease reducing the quality of life of a patient as cause pain, threat pathological fracture, deteriorate limb function, and develop hypercalcemia. Treatment of patients should be comprehensive and base on the rational use of systemic therapy and local impacts ...
A S, Zhabina, T Yu, Semiglazova
openaire   +1 more source

Bone-modifying agents for non–small-cell lung cancer patients with bone metastases during the era of immune checkpoint inhibitors: A narrative review

Seminars in Oncology, 2023
Jeong Uk Lim, Jeongmin Lee, Jeonghoon Ha   +2 more
exaly  

[New bone density conservation agents for osteoporosis under research and development: Ibandronate].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Ikuko, Tanaka, Junko, Hashimoto, Hisaji, Oshima   +2 more
openaire   +1 more source

Bisphosphonate therapy after liver transplant improves bone mineral density and reduces fracture rates: an updated systematic review and meta‐analysis

Transplant International, 2021
Wen Hui Lim, Keng Lin Wong, Cheng Han Ng
exaly  

[New bone density conservation agents for osteoporosis under research and development: Zoledronate].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Seiki, Wada, Takeshi, Fukawa, Sadahiro, Kamiya   +2 more
openaire   +1 more source

The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis

International Journal of Environmental Research and Public Health, 2018
Ulrich Schweiger, Kai Kahl, Eva Fassbinder   +2 more
exaly  

Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence

Therapeutic Advances in Musculoskeletal Disease, 2013
Michael Mcclung
exaly  

[New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Itsuro, Endo, Toshio, Matsumoto
openaire   +1 more source

[New bone density conservation agents for osteoporosis under research and development: Anti-RANKL antibody].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Seiki, Wada, Takeshi, Fukawa, Sadahiro, Kamiya   +2 more
openaire   +1 more source

Bisphosphonates and other bone agents for breast cancer

The Cochrane Library, 2018
Nick Pavlakis, Martin R Stöckler, Annabel Goodwin   +2 more
exaly